Ali Habib • UCI Profiles

Ali A Habib

Title(s)	Health Sciences Professor, Neurology
School	School of Medicine
Address	1001 Health Sciences Road Irvine CA 92697-3950
Phone	(714) 456-6832
vCard	Download vCard

ORNG Applications

Clinical Trials

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Hospitalizations and Mortality From Myasthenia Gravis: Trends From 2 US National Datasets Neurology. 2024 01 23; 102(2):e207863. Habib AA, Sacks N, Cool C, Durgapal S, Dennen S, Everson K, Hughes T, Hernandez J, Phillips G. PMID: 38165317.

View in: PubMed Mentions: Fields:
Neu Neurology
Translation:Humans
A Novel Ergonomic Curette Design Reduces Dental Prophylaxis-Induced Muscle Work and Fatigue. Dent J (Basel). 2023 Nov 28; 11(12). Lin K, Wink C, Dolan B, Osann K, Habib AA, Gehrig J, Wilder-Smith P. PMID: 38132410; PMCID: PMC10742551.

View in: PubMed Mentions:
Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO. Neurol Ther. 2023 Oct; 12(5):1591-1592. Regnault A, Morel T, de la Loge C, Mazerolle F, Kaminski HJ, Habib AA. PMID: 37368226; PMCID: PMC10444721.

View in: PubMed Mentions: 1
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift. Eur J Neurol. 2023 12; 30(12):3644-3645. Habib AA, Schneider-Gold C. PMID: 37578121.

View in: PubMed Mentions: Fields:
Neu Neurology
Translation:Humans
Safety and outcomes with efgartigimod use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice. Muscle Nerve. 2023 Nov; 68(5):762-766. Katyal N, Halldorsdottir K, Govindarajan R, Shieh P, Muley S, Reyes P, Leung KK, Mullen J, Milani-Nejad S, Korb M, Goyal NA, Mozaffar T, Goyal N, Habib AA, Muppidi S. PMID: 37695277.

View in: PubMed Mentions: 2 Fields:
Neu Neurology Phy Physiology
Impact of social determinants of health on individuals living with generalized myasthenia gravis and implications for patient support programs. Front Public Health. 2023; 11:1147489. Hughes T, Anderson AEL, Habib AA, Perez K, Bergin C, Suchotliff S, Zvosec C, McDaniel D, Sato M, Whangbo A, Phillips G. PMID: 37275500; PMCID: PMC10235801.

View in: PubMed Mentions: 1 Fields:
Pub Public Health
Translation:Humans
Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO. Neurol Ther. 2023 Oct; 12(5):1573-1590. Regnault A, Morel T, de la Loge C, Mazerolle F, Kaminski HJ, Habib AA. PMID: 37166675; PMCID: PMC10444722.

View in: PubMed Mentions: 2
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. Lancet Neurol. 2023 05; 22(5):383-394. Bril V, Druzdz A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ, MG0003 study team. PMID: 37059507.

View in: PubMed Mentions: 21 Fields:
Neu Neurology
Translation:Humans CTClinical Trials
Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials. Neurology. 2023 09 05; 101(10):442-451. Guptill JT, Benatar M, Granit V, Habib AA, Howard JF, Barnett-Tapia C, Nowak RJ, Lee I, Ruzhansky K, Dimachkie MM, Cutter GR, Kaminski HJ, for MGNet Clinical Trial Outcome Measure Working Group. PMID: 37076302; PMCID: PMC10491448.

View in: PubMed Mentions: 3 Fields:
Neu Neurology
Translation:Humans
Primary lateral sclerosis natural history study - planning, designing, and early enrollment. Amyotroph Lateral Scler Frontotemporal Degener. 2023 08; 24(5-6):394-404. Mitsumoto H, Jang G, Lee I, Simmons Z, Sherman AV, Heitzman D, Sorenson E, Cheung K, Andrews J, Harms M, Shneider NA, Santella R, Paganoni S, Ajroud-Driss S, Fernandes JAM, Burke KM, Gwathmey K, Habib AA, Maragakis NJ, Walk D, Fournier C, Heiman-Patterson T, Wymer J, Diaz F, Scelsa SN, Elman L, Genge A, Goutman SA, Hayat G, Jawdat O, Johnston WS, Joyce NC, Kasarskis EJ, Kisanuki YY, Lomen-Hoerth C, Pulley MT, Shah JS, Shoesmith C, Zinman L, PLS Natural History Study Group.. PMID: 36576200.

View in: PubMed Mentions: Fields:
Neu Neurology
Translation:Humans PHPublic Health
Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease. Neurology. 2022 Jun 06; 98(23):e2356-e2367. Thomas FP, Brannagan TH, Butterfield RJ, Desai U, Habib AA, Herrmann DN, Eichinger KJ, Johnson NE, Karam C, Pestronk A, Quinn C, Shy ME, Statland JM, Subramony SH, Walk D, Stevens-Favorite K, Miller B, Leneus A, Fowler M, van de Rijn M, Attie KM. PMID: 35545446; PMCID: PMC9202530.

View in: PubMed Mentions: 7 Fields:
Neu Neurology
Intron mutations and early transcription termination in Duchenne and Becker muscular dystrophy. Hum Mutat. 2022 04; 43(4):511-528. Waldrop MA, Moore SA, Mathews KD, Darbro BW, Medne L, Finkel R, Connolly AM, Crawford TO, Drachman D, Wein N, Habib AA, Krzesniak-Swinarska MA, Zaidman CM, Collins JJ, Jokela M, Udd B, Day JW, Ortiz-Guerrero G, Statland J, Butterfield RJ, Dunn DM, Weiss RB, Flanigan KM. PMID: 35165973; PMCID: PMC9901284.

View in: PubMed Mentions: 6 Fields:
Gen Genetics
Translation:Humans Cells
Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study. Neurotherapeutics. 2021 Jul; 18(3):2130. Rudnicki SA, Andrews JA, Duong T, Cockroft BM, Malik FI, Meng L, Wei J, Wolff AA, Genge A, Johnson NE, Tesi-Rocha C, Connolly AM, Darras BT, Felice K, Finkel RS, Shieh PB, Mah JK, Statland J, Campbell C, Habib AA, Kuntz NL, Oskoui M, Day JW. PMID: 34731415; PMCID: PMC8609058.

View in: PubMed Mentions: Fields:
Neu Neurology
Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study. Neurotherapeutics. 2021 04; 18(2):1127-1136. Rudnicki SA, Andrews JA, Duong T, Cockroft BM, Malik FI, Meng L, Wei J, Wolff AA, Genge A, Johnson NE, Tesi-Rocha C, Connolly AM, Darras BT, Felice K, Shieh PB, Mah JK, Statland J, Campbell C, Habib AA, Kuntz NL, Oskoui M, Day JW, Finkel RS. PMID: 33624184; PMCID: PMC8423982.

View in: PubMed Mentions: 12 Fields:
Neu Neurology
Translation:Humans CTClinical Trials
Attitudes Toward Noninterventional Observational Studies in US and Australian Patients With Sporadic Inclusion Body Myositis. J Clin Neuromuscul Dis. 2020 Jun; 21(4):246-247. Mathew V, Wencel M, Habib AA, Goyal NA, Needham M, Mozaffar T. PMID: 32453104.

View in: PubMed Mentions: Fields:
Neu Neurology Phy Physiology
Translation:Humans
Update on immune-mediated therapies for myasthenia gravis. Muscle Nerve. 2020 11; 62(5):579-592. Habib AA, Ahmadi Jazi G, Mozaffar T. PMID: 32462710.

View in: PubMed Mentions: 4 Fields:
Neu Neurology Phy Physiology
Translation:Humans
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. JAMA Neurol. 2020 05 01; 77(5):582-592. Howard JF, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ, Zilucoplan MG Study Group, Barohn R, Dimachkie M, Pasnoor M, Farmakidis C, Liu T, Colgan S, Benatar MG, Bertorini T, Pillai R, Henegar R, Bromberg M, Gibson S, Janecki T, Freimer M, Elsheikh B, Matisak P, Genge A, Guidon A, David W, Habib AA, Mathew V, Mozaffar T, Hinton JL, Hewitt W, Barnett D, Sullivan P, Ho D, Howard JF, Traub RE, Chopra M, Kaminski HJ, Aly R, Bayat E, Abu-Rub M, Khan S, Lange D, Holzberg S, Khatri B, Lindman E, Olapo T, Sershon LM, Lisak RP, Bernitsas E, Jia K, Malik R, Lewis-Collins TD, Nicolle M, Nowak RJ, Sharma A, Roy B, Nye J, Pulley M, Berger A, Shabbir Y, Sachdev A, Patterson K, Siddiqi Z, Sivak M, Bratton J, Small G, Kohli A, Fetter M, Vu T, Lam L, Harvey B, Wolfe GI, Silvestri N, Patrick K, Zakalik K, Duda PW, MacDougall J, Farzaneh-Far R, Pontius A, Hoarty M. PMID: 32065623; PMCID: PMC7042797.

View in: PubMed Mentions: 65 Fields:
Neu Neurology
Translation:Humans CTClinical Trials
Therapeutic strategies for diabetic neuropathy. Curr Neurol Neurosci Rep. 2010 Mar; 10(2):92-100. Habib AA, Brannagan TH. PMID: 20425233.

View in: PubMed Mentions: 21 Fields:
Neu Neurology
Translation:Humans
The neuropathology of leprosy. Arch Neurol. 2002 Jan; 59(1):138-40. Habib AA, Mozaffar T. PMID: 11790242.

View in: PubMed Mentions: Fields:
Neu Neurology
Translation:Humans